• / Free eNewsletters & Magazine
  • / My Account
Home>Express Scripts Awarded 7-Year TRICARE Pharmacy Program Contract

Express Scripts Awarded 7-Year TRICARE Pharmacy Program Contract

3party Content

Fri, 18 Apr 2014

ST. LOUIS, April 18, 2014 /PRNewswire/ -- The U.S. Department of Defense today awarded Express Scripts (NASDAQ: ESRX) administration of the TRICARE Pharmacy Program, Fourth Generation (TPharm4) contract serving approximately 10 million beneficiaries. "Express Scripts is proud to continue providing
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.